Alice Ricke Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 |
Timothy James Mathes Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 |
Thomas Locker, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 |
Cristin Peetoom, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2022 E 16th St, Wellington, KS 67152 Phone: 620-326-3321 Fax: 620-326-8012 |
Teri Will Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 |
Jeffrey Lee Janzen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 |
Garry Wartick Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 |
Craig Bower, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2022 E 16th St, Wellington, KS 67152 Phone: 620-326-3321 |
Marc Wilson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2022 E 16th St, Wellington, KS 67152 Phone: 620-326-3321 |
News Archive
Researchers based at Imperial College London, UK, have recently highlighted the effects of these deleterious CS mutations through a ferret animal model, demonstrating that furin cleavage sites are a necessary component in the virus' ability to replicate.
Daiichi Sankyo Company, Ltd. (hereinafter Daiichi Sankyo) and Ambit Biosciences, jointly announced today that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis.
Nothing in the Supreme Court arguments in the health care case last week, or in the subsequent commentary, has changed my opinion that this is an easy case. It's the court that made it look hard (Linda Greenhouse, 4/4).
A review of the published literature and of internal company documents from the manufacturer of cerivastatin, a cholesterol lowering drug removed from the market in 2001, suggests that information about serious adverse effects of this medication was known to the company within months after this drug was launched
Researchers at Children's Hospital Boston and the Howard Hughes Medical Institute have, for the first time, captured the electrical activity of a single sperm cell. The technically difficult maneuver, reported in Nature, allows the first measurement of the currents that flow across the sperm's outer membrane.
› Verified 4 days ago